Aims and scope
Journal of Negative Results in BioMedicine is an open access, peer-reviewed journal that provides a platform for the publication and discussion of non-confirmatory and "negative" data, as well as unexpected, controversial and provocative results in the context of current tenets.
Journal of Negative Results in BioMedicine aims to encourage scientists and physicians of all fields to publish results that challenge current models, tenets or dogmas. The journal invites scientists and physicians to submit work that illustrates how commonly used methods and techniques are unsuitable for studying a particular phenomenon. Journal of Negative Results in BioMedicine strongly promotes and invites the publication of clinical trials that fall short of demonstrating an improvement over current treatments. The aim of the journal is to provide scientists and physicians with responsible and balanced information in order to improve experimental designs and clinical decisions.
Articles published in traditional journals frequently provide insufficient evidence regarding negative data. They hardly allow a rigorous evaluation of the quality of these results. In addition, controversial results that refute a current model or simply negative results within a current dogma, frequently meet considerable resistance before they are acknowledged. This is particularly the case if current techniques and technologies are too crude to shed further light on the findings. As more sophisticated techniques become available such findings may turn out to have been groundbreaking only decades later.
Not every unexpected observation, controversial conclusion or proposed model will turn out to be of such groundbreaking significance. Nor will they even be confirmed by subsequent scientific progress. However, we strongly believe that such "negative" observations and conclusions, based on rigorous experimentation and thorough documentation, ought to be published in order to be discussed, confirmed or refuted by others. In addition, publishing well documented failures may reveal fundamental flaws and obstacles in commonly used methods, drugs or reagents such as antibodies or cell lines, ultimately leading to improvements in experimental designs and clinical decisions.
All articles published by Journal of Negative Results in BioMedicine are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Journal of Negative Results in BioMedicine you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Journal of Negative Results in BioMedicine therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
Journal of Negative Results in BioMedicine is involved in a pilot study of new technology enabling the setting of article processing charges (APCs) at an article-type level within a journal instead of charging at a flat rate. APCs on this journal are as follows for the duration of the pilot:
|Article type||APC GBP||APC EUR||APC USD|
Payments from within the EU are subject to VAT. EU customers must supply their VAT Number to be exempt from VAT charge. UK Customers are not exempt from VAT charge.
BioMed Central provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
All articles published in Journal of Negative Results in BioMedicine are included in:
- Emerging Sources Citation Index
- PubMed Central
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services including Web of Science (Thomson Reuters) to ensure that articles published in Journal of Negative Results in BioMedicine will be available in their databases when appropriate.
Journal of Negative Results in BioMedicine operates an open peer-review system, where the reviewers' names are included on the peer review reports for authors. In addition, if the article is published, the named reviewer reports are published online alongside the article under a Creative Commons Attribution License 4.0. Previous versions of the manuscript and all author responses to the reviewers are available by contacting firstname.lastname@example.org.
The benefit of open peer review is that it increases transparency. The peer reviewers and Editors are fully accountable for the decisions made, bias is reduced as reviewer reports are named, published reports can serve an educational purpose in helping facilitate training and research into peer review, and reviewers can get credit for their work.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
All manuscripts submitted to Journal of Negative Results in BioMedicine should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Journal of Negative Results in BioMedicine
Articles in Journal of Negative Results in BioMedicine should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. J Negat Results BioMed [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. J Negat Results BioMed 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Journal of Negative Results in BioMedicine
Journal of Negative Results in BioMedicine's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Journal of Negative Results in BioMedicine offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Journal of Negative Results in BioMedicine gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Journal of Negative Results in BioMedicine are included in article alerts and regular email updates. Some may be highlighted on Journal of Negative Results in BioMedicine’s pages and on the BioMed Central homepage.
In addition, articles published in Journal of Negative Results in BioMedicine may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Journal of Negative Results in BioMedicine. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Journal of Negative Results in BioMedicine you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.